News Archive

Date: 03/13/2012
Two studies published March 6 in the Journal of the National Cancer Institute provide insights about the CYP2D6 genotype in postmenopausal breast cancer patients and represent a major step forward in understanding the usefulness of CYP2D6 testing for deciding whether or not a patient should receive adjuvant tamoxifen for treatment of early-stage breast cancer.
Date: 03/12/2012
Two studies published March 6 in the Journal of the National Cancer Institute provide insights about the CYP2D6 genotype in postmenopausal breast cancer patients and represent a major step forward in understanding the usefulness of CYP2D6 testing for deciding whether or not a patient should receive adjuvant tamoxifen for treatment of early-stage breast cancer.
Date: 02/29/2012
Lilly Oncology on Canvas art exhibition, featuring art by cancer survivors, visits the University of Michigan Comprehensive Cancer Center for three weeks in March.
Date: 02/28/2012
Lilly Oncology on Canvas art exhibition, featuring art by cancer survivors, visits the University of Michigan Comprehensive Cancer Center for three weeks in March.
Date: 02/16/2012
National Institute of Health names University of Michigan anesthesiologist Carman Green, M.D. to new Interagency Pain Research Coordinating Committee.
Date: 02/10/2012
Cancer research depends on people volunteering to participate in clinical studies.
Date: 02/08/2012
Chat participants can ask questions of U-M lung cancer doctorWritten by Justin Harris; contact at 734-764-2220 or juaha@umich.edu.
Date: 02/06/2012
Understanding how cancer cells survive is a primary focus of investigation in Elizabeth R. Lawlor's researchWritten by Margarita Wagerson; contact at 734-764-2220.
Date: 01/31/2012
A mutant protein found in nearly all pancreatic cancers plays a role not only in the cancer's development but in its continued growth, according to a new study from University of Michigan Comprehensive Cancer Center researchers.
Date: 01/25/2012
Researchers at the University of Michigan, led by Max Wicha, M.D., have found that Avastin, Sutent increase breast cancer stem cells. This could explain the limited success of anti-angiogenesis treatments in breast cancer.

Pages